CLINICAL_TRIALS
trial_result
· 2020-12-01
Clinical Trial Update: Effect of Obesity on Immune Response to Pneumovax 23
Summary
Clinical trial assessing how obesity affects the immune response to Pneumovax 23 has completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Florida | Conditions: Obesity | Status: COMPLETED | Results posted: 2020-12-01